Categories

Archive for the ‘TUMOURS & GROWTHS’ Category

Precision Medicine: What Is Cancer, Really? Scientists overview here.

Monday, May 22nd, 2017

The men and women who are trying to bring down cancer are starting to join forces rather than work alone. Together, they are winning a few of the battles against the world’s fiercest disease. For this unprecedented special report, we visited elite cancer research centers around the country to find out where we are in the war.

I. Precision Medicine: What Is Cancer, Really?

When you visit St. Jude Children’s Research Hospital in Memphis, Tennessee, you expect to feel devastated. It starts in the waiting room. Oh, here we go with the little red wagons, you think, observing the cattle herd of them rounded up by the entrance to the Patient Care Center. Oh, here we go with the crayon drawings of needles. The itch begins at the back of your throat, and you start blinking very fast and mentally researching how much money you could donate without starving. Near a row of arcade games, a preteen curls his face into his mother’s shoulder while she strokes his head. Oh, here we go.

But the more time you spend at St. Jude, the more that feeling is replaced with wonder. In a cruel world you’ve found a free hospital for children, started by a Hollywood entertainer as a shrine to the patron saint of lost causes. There is no other place like this. Corporations that have nothing to do with cancer—nothing to do with medicine, even—have donated vast sums of money just to be a part of it. There’s a Chili’s Care Center. The cafeteria is named for Kay Jewelers.

Scott Newman’s office is in the Brooks Brothers Computational Biology Center, where a team of researchers is applying computer science and mathematics to the question of why cancer happens to children. Like many computer people, Newman is very smart and a little quiet and doesn’t always exactly meet your eyes when he speaks to you. He works on St. Jude’s Genomes for Kids project, which invites newly diagnosed patients to have both their healthy and tumor cells genetically sequenced so researchers can poke around.

“Have you seen a circle plot before?” Newman asks, pulling out a diagram of the genes in a child’s cancer. “If I got a tattoo, it would be one of these.” Around the outside of the circle plot is something that looks like a colorful bar code. Inside, a series of city skylines. Through the center are colored arcs like those nail-and-string art projects students make in high school geometry class. The diagram represents everything that has gone wrong within a child’s cells to cause cancer. It’s beautiful.

A Genetic Disaster: This circular visualization shows real gene mutations found in 3,000 pediatric cancers at St. Jude Children’s Research Hospital. Genes with sequence mutations are labeled in blue; those with structural variations are in red; and those

“These are the genes in this particular tumor that have been hit,” Newman says in a Yorkshire accent that emphasizes the t at the end of the word hit in a quietly violent way. “And that’s just one type of thing that’s going on. Chromosomes get gained or lost in cancer. This one has gained that one, that one, that one, that one,” he taps the page over and over. “And then there are structural rearrangements where little bits of genome get switched around.” He points to the arcs sweeping across the page. “There are no clearly defined rules.”

It’s not like you don’t have cancer and then one day you just do. Cancer—or, really, cancers, because cancer is not a single disease—happens when glitches in genes cause cells to grow out of control until they overtake the body, like a kudzu plant. Genes develop glitches all the time: There are roughly twenty thousand genes in the human body, any of which can get misspelled or chopped up. Bits can be inserted or deleted. Whole copies of genes can appear and disappear, or combine to form mutants. The circle plot Newman has shown me is not even the worst the body can do. He whips out another one, a snarl of lines and blocks and colors. This one would not make a good tattoo.

“As a tumor becomes cancerous and grows, it can accumulate many thousands of genetic mutations. When we do whole genome sequencing, we see all of them,” Newman says. To whittle down the complexity, he applies algorithms that pop out gene mutations most likely to be cancer-related, based on a database of all the mutations researchers have already found. Then, a genome analyst manually determines whether each specific change the algorithm found seems likely to cause problems. Finally, the department brings its list of potentially important changes to a committee of St. Jude’s top scientists to discuss and assign a triage score. The mutations that seem most likely to be important get investigated first.

It took thirteen years and cost $2.7 billion to sequence the first genome, which was completed in 2003. Today, it costs $1,000 and takes less than a week. Over the last two decades, as researchers like Newman have uncovered more and more of the individual genetic malfunctions that cause cancer, teams of researchers have begun to tinker with those mutations, trying to reverse the chaos they cause. (The first big success in precision medicine was Gleevec, a drug that treats leukemias that are positive for a common structural rearrangement called the Philadelphia chromosome. Its launch in 2001 was revolutionary.) Today, there are eleven genes that can be targeted with hyperspecific cancer therapies, and at least thirty more being studied. At Memorial Sloan Kettering Cancer Center in New York City, 30 to 40 percent of incoming patients now qualify for precision medicine studies.

Charles Mullighan,a tall, serious Australian who also works at St. Jude, is perhaps the ideal person to illustrate how difficult it will be to cure cancer using precision medicine. After patients’ cancer cells are sequenced, and the wonky mutations identified, Mullighan’s lab replicates those mutations in mice, then calls St. Jude’s chemical library to track down molecules—some of them approved medicines from all over the world, others compounds that can illuminate the biology of tumors—to see if any might help.

New York: Britta Weigelt and Jorge Reis-Filho use police forensics techniques to repair old tumor samples at Memorial Sloan Kettering so the samples can be genetically profiled.

If Mullighan is lucky, one of the compounds he finds will benefit the mice, and he’ll have the opportunity to test it in humans. Then he’ll hope there are no unexpected side effects, and that the cancer won’t develop resistance, which it often does when you futz with genetics. There are about twenty subtypes of the leukemia Mullighan studies, and that leukemia is one of a hundred different subtypes of cancer. This is the kind of precision required in precision cancer treatment—even if Mullighan succeeds in identifying a treatment that works as well as Gleevec, with the help of an entire, well-funded hospital, it still will work for only a tiny proportion of patients.

Cancer is not an ordinary disease. Cancer is the disease—a phenomenon that contains the whole of genetics and biology and human life in a single cell. It will take an army of researchers to defeat it.

Luckily, we’ve got one.

Interlude

“I used to do this job out in L.A.,” says the attendant at the Hertz counter at Houston’s George Bush Intercontinental Airport. “There, everyone is going on vacation. They’re going to the beaach or Disneyland or Hollywood or wherever.

“Because of MD Anderson, I see more cancer patients here. They’re so skinny. When they come through this counter, they’re leaning on someone’s arm. They can’t drive themselves. You think, there is no way this person will survive. And then they’re back in three weeks, and in six months, and a year. I’m sure I miss some, who don’t come through anymore because they’ve died. But the rest? They come back.”

II. Checkpoint Inhibitor Therapy: You Have the Power Within You!

On a bookshelf in Jim Allison’s office at MD Anderson Cancer Center in Houston (and on the floor surrounding it) are so many awards that some still sit in the boxes they came in. The Lasker-DeBakey Clinical Medical Research Award looks like the Winged Victory statue in the Louvre. The Breakthrough Prize in Life Sciences, whose benefactors include Sergey Brin, Anne Wojcicki, and Mark Zuckerberg, came with $3 million.

“I gotta tidy that up sometime,” Allison says.

Allison has just returned to the office from back surgery that fused his L3, L4, and L5 vertebrae, which has slightly diminished his Texas rambunctiousness. Even on painkillers, though, he can explain the work that many of his contemporaries believe will earn him the Nobel Prize: He figured out how to turn the immune system against tumors.

“One day, the miracles won’t be miracles at all. They’ll just be what happens.”

Allison is a basic scientist. He has a Ph.D., rather than an M.D., and works primarily with cells and molecules rather than patients. When T-cells, the most powerful “killer cells” in the immune system, became better understood in the late 1960s, Allison became fascinated with them. He wanted to know how it was possible that a cell roaming around your body knew to kill infected cells but not healthy ones. In the mid-1990s, both Allison’s lab and the lab of Jeffrey Bluestone at the University of Chicago noticed that a molecule called CTLA-4 acted as a brake on T-cells, preventing them from wildly attacking the body’s own cells, as they do in autoimmune diseases.

Allison’s mother died of lymphoma when he was a child and he has since lost two uncles and a brother to the disease. “Every time I found something new about how the immune system works, I would think, I wonder how this works on cancer?” he says. When the scientific world discovered that CTLA-4 was a brake, Allison alone wondered if it might be important in cancer treatment. He launched an experiment to see if blocking CTLA-4 would allow the immune system to attack cancer tumors in mice. Not only did the mice’s tumors disappear, the mice were thereafter immune to cancer of the same type.

Ipilimumab (“ipi” for short) was the name a small drug company called Medarex gave the compound it created to shut off CTLA-4 in humans. Early trials of the drug, designed just to show whether ipi was safe, succeeded so wildly that Bristol Myers Squibb bought Medarex for $2.4 billion. Ipilimumab (now marketed as Yervoy) became the first “checkpoint inhibitor”: It blocks one of the brakes, or checkpoints, the immune system has in place to prevent it from attacking healthy cells. Without the brakes the immune system can suddenly, incredibly, recognize cancer as the enemy.

“You see the picture of that woman over there?” Allison points over at his desk. Past his lumbar-support chair, the desk is covered in papers and awards and knickknacks and frames, including one containing a black card with the words “Never never never give up” printed on it. Finally, the photo reveals itself, on a little piece of blue card stock.

That’s the first patient I met,” Allison says. “She was about twenty-four years old. She had metastatic melanoma. It was in her brain, her lungs, her liver. She had failed everything. She had just graduated from college, just gotten married. They gave her a month.”

The woman, Sharon Belvin, enrolled in a phase-two trial of ipilimumab at Memorial Sloan Kettering, where Allison worked at the time. Today, Belvin is thirty-five, cancer- free, and the mother of two children. When Allison won the Lasker prize, in 2015, the committee flew Belvin to New York City with her husband and her parents to see him receive it. “She picked me up and started squeezing me,” Allison says. “I walked back to my lab and thought, Wow, I cure mice of tumors and all they do is bite me.” He adds, dryly, “Of course, we gave them the tumors in the first place.”

After ipi, Allison could have taken a break and waited for his Nobel, driving his Porsche Boxster with the license plate CTLA-4 around Houston and playing the occasional harmonica gig. (Allison, who grew up in rural Texas, has played since he was a teenager and once performed “Blue Eyes Crying in the Rain” onstage with Willie Nelson.) Instead, his focus has become one of two serious problems with immunotherapy: It only works for some people.

So far, the beneficiaries of immune checkpoint therapy appear to be those with cancer that develops after repeated genetic mutations—metastatic melanoma, non-small-cell lung cancer, and bladder cancer, for example. These are cancers that often result from bad habits like smoking and sun exposure. But even within these types of cancer, immune checkpoint therapies improve long-term survival in only about 20 to 25 percent of patients. In the rest the treatment fails, and researchers have no idea why.

Lately, Allison considers immune checkpoint therapy a “platform”—a menu of treatments that can be amended and combined to increase the percentage of people for whom it works. A newer drug called Keytruda that acts on a different immune checkpoint, PD-1, knocked former president Jimmy Carter’s metastatic melanoma into remission in 2015. Recent trials that blocked both PD-1 and CTLA-4 in combination improved long-term survival in 60 percent of melanoma patients. Now, doctors are combining checkpoint therapies with precision cancer drugs, or with radiation, or with chemotherapy. Allison refers to this as “one from column A, and one from column B.”

The thing about checkpoint inhibitor therapy that is so exciting—despite the circumscribed group of patients for whom it works, and despite sometimes mortal side effects from the immune system going buck-wild once the brakes come off—is the length of time it can potentially give people. Before therapies that exploited the immune system, response rates were measured in a few extra months of life. Checkpoint inhibitor therapy helps extremely sick people live for years. So what if it doesn’t work for everyone? Every cancer patient you can add to the success pile is essentially cured.

Jennifer Wargo and team remove lymph nodes from a melanoma patient.

THE BLACK SALVE SELF TREATMENT FOR CANCERS TRUE STORY HERE & 22 BLACK SALVE VIDEOS ALSO IN THIS SITE

Monday, November 28th, 2016
This is a story of an individual using the black Salve to treat his cancer with huge success.

black-salve-on-tumour-at-work image www.newcures.info

The following paragraphs and pictures are a personal account of a six and a half year struggle with a pathogen on the surface of my back. The pictures are graphic but I felt it was necessary for people who may have a similar problem to see them, in order to be encouraged that the growth/pathogen, has been destroyed and eliminated from my body once and for all and with a very simple remedy.

About six and a half years ago I was planning a trip to Florida and decided, instead of getting burned down there, I would try a tanning bed to prepare my skin for the powerful rays closer to the equator. If any one tells you that these sun beds are safe they are misleading you! I was in for 10 minutes, that’s all it took to cause the damage. I will say this, I did have a pre-existing condition called tinea-versicolor. The Dermatologic Disease Database defines it as “Tinea versicolor is caused by a yeast type of skin fungus, which is present on normal skin. If the skin is oily enough, warm enough and moist enough, it starts to grow into small “colonies” on the surface of the skin.” Earlier work by the late Dr. Royal Rife showed that cancer is a virus that, when in the right medium/conditions, can mutate into a bacteria or fungus and back to a virus, and that a bacteria and fungus can also mutate into the others and back.

So, my belief is that the radiation from the rays of the tanning bed hit the tinea versicolor (fungus) and mutated it into a new pathogen that started destroying my skin and growing into a mass, not just on the surface, but well below also. On 4/26/05 I put an herbal preparation of Black Salve on, what was at the time a mass about the size of a half dollar. Over the years it looked like cauliflower on the surface of the skin which would bleed quite a bit so I wore band-aids over it for years. Effective Black Salve is next to impossible to find in the US but you can find it if you look hard enough. I felt tingling and then a burning sensation almost immediately after the application. Some people have felt the need to take aspirin or pain killers to help maintain the pain, I believe it will depend upon each individual case, but better to be prepared by having some on hand if the pain gets to be too much. That night the area around the spot swelled all around and out from it until the perimeter of swelling was about the size of a mans fist. The next morning I woke up and took a shower and the excess Black Salve washed off and left behind an indentation of the skin by about 3 millimeters which was covered by a black scab or eschar.

I applied another coating of Black Salve the second night just to make sure, and the pain got even worse than the night before, which led me to believe that the first application may not have been enough. I never did put on a third application as was suggested to me by a friend who has dealt with many cases. Here you can see what the eschar looks like as it begins to pull away from the healthy skin. That is a quarter next to it in the picture

A couple of days before the first application I began taking whole food supplements which helped my immune system greatly! Spanish Black Radish 2 tablets per meal, increasing to 7 tablets per meal after the first application of Black Salve and for the entire month following. The Spanish Black Radish helped dramatically reduce the weeping of pus and debris from the wound, it is an awesome product when taken correctly! Many people have had to change their bandages 4 or more times a day because there is so much leakage of pus, but with the Spanish Black Radish, all the pus was eliminated internally through the lymphatic system and I actually left the same bandage on all day, only changing it the following mornings after getting out of the shower. Here you can see what the wound looked like after the eschar fell out on day six from the first application.

The crater it left behind was pretty deep, but the second the eschar fell out the pain was completely gone! In the next two pictures below you see what the growth looked like from its underside. Pretty nasty! The pic next to it shows how deep it was. That is a quarter laying flat next to it, so as you can see, in certain parts of the growth it was the thickness of 5-6 quarters if they were stacked on top of each other!

Now comes the easy part, healing! I used/use two specific formulas to assist my healing over the area with new tissue. The special body wash and also organic coconut oil from www.bionutz.com . Some areas take as long as a year to completely heal. I do not think mine will take that long because of the aid of these 2 products but I will take them until I am satisfied with the look of the new skin. Below are the last two pictures, one at 2 weeks after the eschar fell out and the second at two months after the eschar fell out. As you can see, the wound is completely healed over and some scar tissue remains, which I will continue to take the special body wash and also organic coconut oil until I feel it is totally finished healing.

 


Hi
I have successfully used black salve on myself and on my mother-in-law. Myself I have photos taken of the various stages of the healing process.


Contact us for more info

Top-banner-lingeriecrossover-10.08.15

Henry Sapiecha

 

 

 

 

 

 

 

 

 

Brain scan reveals tumour the size of a fist

Saturday, November 19th, 2016

A tumour the size of a lemon was discovered in Kayla Geltch's skull.image www.nwcures.info

A tumour the size of a lemon was discovered in Kayla Geltch’s skull.

IT TOOK Kayla Geltch to be on the brink of death before she was finally given a brain scan.

What they scan revealed shocked everyone.

It located a brain tumour the size of a lemon inside her head.

The tumour had moulded into the skull signifying that it had been there for a long time… maybe even since birth.

Recalling back on the moment she was told the news, Kayla’s mum Katrina said it made her soul ache.

“It breaks my heart,” she said.

“I just couldn’t talk when we were told.

“We’ve been pushing for a brain scan for a while, and this is what it took to get one.”

Kayla Geltch, 19, will soon undergo life changing surgery to remove some of her brain tumour.image www.newcures.info

Kayla Geltch, 19, will soon undergo life changing surgery to remove some of her brain tumour.

Kayla, 19, has a range of disabilities which includes autism and Asperger’s.

She is mobile but doesn’t speak, and requires full-time care.

About four weeks ago, Kayla had a seizure which almost had a fatal end.

Ms Geltch’s partner Matt Liston has been with the family as the tragedy unfolded.

She was practically dead for 10 minutes, before ambulance arrived,” he said.

What really shook Ms Geltch is the concept that the tumour could have been there lifelong.

“Her behaviour was dismissed as an autism meltdown,” Ms Geltch said.

“She was given medication specifically for that.”

Kayla was transported to the Royal Brisbane Hospital shortly after and that is where she is now.

In the coming days, she will have surgery on the tumour.

Due to its fragile placement, that surgery comes with its own set of risks giving Ms Geltch even more things to stress about.

Ms Geltch is currently waiting for a surgery for her own medical condition, and is physically not able to transport to Brisbane at this very moment.

We have been talking to the doctors every day and seeing how she is going,” Ms Geltch said.

Mr Liston is traveling to Brisbane soon to be with Kayla.

During this difficult time, Kayla’s family is reaching out to the community for help.

A GoFundMe page has been set up, allowing for people to donate.

“We don’t know what will happen after Kayla’s surgery, or what the fees will be,” Ms Geltch said.

“We may need to move down to Brisbane permanently.”

The family also has two other children to take care of.

The GoFundMe page can be found at gofundme.com/2vl1t2c.

And for those who would like to donate but would like to give in cash, head to Le petit chocolatier Hervey Bay.

“Our experience is also a warning for other parents with disabled children, that something that is wrong with them, could be something different from what it appears,” Ms Geltch said.

“They thought she just had behavioural problems, but it turned out to be a tumour.”

Katrina and Kayla Geltch have some mother and daughter fun.image www.newcures.info

Top-banner-lingeriecrossover-10.08.15

Henry Sapiecha

Seeds of hope for cancer victims Video & story

Saturday, September 10th, 2016

blushwood-berries -in-hand image www.newcures.info

Dr Victoria Gordon and Dr Paul Reddell have discovered a compound EBC-46 that may transform cancer treatment in the fruit of the Brushwood tree in the rainforest on the Atherton tablelands.North Queensland Australia  Source: News Limited

VICTORIA Gordon holds in her hands the chance at life that she had to deny her cancer-stricken sister: a potential breakthrough drug that “eats” tumours.

Dr Gordon and her husband, fellow scientist Paul Reddell, discovered the compound in a north Queensland rainforest and have spent nearly a decade developing the drug and dem­onstrating its effectiveness in ­animals.

Hundreds of horses, dogs, cats, even a Tasmanian devil had life-threatening tumours reduced to harmless sludge by the experimental drug, EBC-46, produced from the seed of the common blushwood tree.

Now, at last, it is to be tested on people battling advanced melanoma and notoriously difficult to treat head and neck cancers. Clinical trials are set to get under way in a number of hospitals by September.

Dr Gordon and Dr Reddell realised something special was happening when they saw hungry rat kangaroos spit out fallen berries from the blushwood tree, which grows only in the tropical rainforests of the Atherton Tablelands, west of Cairns.

The chemical responsible for this “feeding deterrent’’ turned out to be EBC-46, propelling Dr Gordon to her moment of truth with her dying sister, Cheryl.

The 61-year-old chef begged Dr Gordon to toss away the rule book and let her have the experimental drug before she succumbed last December to liver cancer. “I couldn’t,’’ a tearful Dr Gordon says, for the first time telling her story of scientific discovery and its anguished denouement with her older sister.

“Basically, the question Cheryl asked was, ‘Do you believe EBC-46 could help me, and can I have the drug?’ Factually, I said to her we were unsure of the role EBC-46 would play in liver cancer and, even so, this is a drug that has not yet been approved for human use. And, as such, no, she could not use the drug. I just had to be … cold and clinical with that. It was heartbreaking.’’

Dr Gordon and Dr Reddell have been reluctant to speak in detail about EBC-46 until now, with the clinical phase I/II human trial in sight. If all goes to plan, the program will begin within months with about 30 cancer patients, all of them “at the end of the line’’ with conventional treatments.

Turning down her sister was the hardest thing Dr Gordon has had to do. “We are asked almost on a daily basis for access to this drug,’’ she says. “I am sincere when I say this … as much as I would dearly love to help those in need, it’s simply not an option. The regulators and the rules are there to protect patients. Yes, we have very good results in the animals. But if we have not proven this drug is a safe drug to use in people, there is no way we should be making it available.’’

>>>>More CLINICAL information please read this original research work.

Atherton vet Justine Campbell, one of the first to treat pets with the drug, said she was approached by a client who had terminal melanoma. “He was desperate,’’ she said. “He had heard about EBC-46 and asked, ‘Can you treat me?’ And I had to say to him, to his face, ‘I’m sorry, I can’t.’ It’s just awful.’’

Years of research into the drug’s effectiveness in animals have been submitted for publication in an international scientific journal by Dr Gordon, Dr Reddell and scientists from Brisbane’s QIMR Berghofer Medical Research Institute.

The head of the institute’s Cancer Drug Mechanism Group, Glen Boyle, said the drug broke down tumours within hours of being injected into them. Human melanoma grown on the skin of laboratory mice began to swell by the time the animals were returned to their cage, a sign the powerful response triggered by the drug was choking off the tumour’s blood supply. Minutes later, the growth was a bruised purple, a sign the cancer cells were dying.

“A couple of days after that there is a scab where the tumour used to be,’’ said Dr Boyle, the lead author of research paper.

Veteran medical scientist Peter Parsons said fieldwork with cancer-struck animals outside the laboratory increased his confidence that the drug would work on most tumour types — and in people.

QBiotics, the company established by Dr Gordon and Dr Reddell, both 54, says the drug destroyed all traces of tumour or shrank them by more than half in 78 per cent of the 344 companion animals treated by vets, including Ms Campbell.

Dr Gordon insists “it’s time, we need to get this into people’’.

For her, the clock is ticking in a personal sense. In addition to losing her sister to cancer, both her parents and grandparents died of a disease that will kill more than 44,000 Australians this year. “I have already lost loved ones. I’m sure that more of my family will present with cancer, as my sister did. I wasn’t ready for her. So I have some incentive, real incentive, to get this drug through.’’

MY EARLIER BLUSHWOOD TREE POSTINGS >> 

ONE    +   TWO   +  THREE

Beautiful_Russian_2_300_250

Henry Sapiecha

You’ve Heard Of Skin Cancer, But Did You Know There is nail cancer as well-Video report here.

Thursday, October 15th, 2015

Everyone knows that if you see a mole or a freckle that looks strange in color or size, you should get it checked out. It’s important to catch these potentially cancerous masses before they turn into something deadly.

But have you ever heard of anyone finding cancerous tissue in their fingernails? Well, it can happen. Just as cancer can affect the skin, it can also affect the skin under your nails, and it usually manifests as a dark-colored stripe or streak that gradually increases in size and darkness.

The cancerous tissue, according to nail specialist Dr. Dana Stern, affects the nail matrix.

These bizarre lines on fingernails aren't always signs of cancer image-2 www.newcures.info

Keeping an eye on yourself is always a good idea. If you see or feel anything out of the ordinary, seek medical help as soon as possible to make sure that nothing serious is happening. If something serious is the cause, early detection and treatment will greatly increase your chances of making a full recovery.

These bizarre lines on fingernails aren't always signs of cancer image www.newcures.info

Most nail markings are actually the result of vitamin or mineral deficiencies.

Dr. Stern says that the thumb, index finger, and big toe are the most common digits affected by this strange form of cancer.

The nail matrix sits near the cuticle, and it’s where all fingernails and toenails originate.

These bizarre lines aren’t always signs of cancer, but it’s best to get them looked at.

2_banner

Henry Sapiecha

Woman finds she is carrying 5kg tumour instead of baby

Friday, May 15th, 2015

pregnant woman in black image www.newcures.info

A Romanian woman has been left devastated after she turned up at hospital expecting to give birth only to find her belly bulge was a tumour.

Madalina Neagu, 42, arrived at Botosani County Hospital in northern Romania with severe abdomen pain believing she was in labour, .

After performing emergency tests Dr Dorin Scladan said he was shocked to find a 5kg tumour inside her uterus.

“As the woman told us she was pregnant, we initially expected pregnancy complications,” Dr Dorin Scladan said.

“In fact, the size of her belly was quite similar to that of a nine-month pregnant woman, so we didn’t have any reason to doubt what she told us.”

A team of doctors removed the tumour from Ms Neagu and then transferred her to intensive care.

Dr Scladan said he expects Ms Neagu to make a full recovery.

“We don’t often see a tumour of this size and in this location. It was a record tumour for the region in the past 15 years,” Dr Scladan said.

It is not known how far along the woman thought she was in her pregnancy or why the tumour was not detected earlier.

ooo

Henry Sapiecha

Asbestos victim wins right to claim compensation from miner for malignant mesothelioma

Monday, March 16th, 2015

Malignant mesothelioma caused by asbestos judge says he is satisfied on that point in court claim

A former Gove [Australia] alumina refinery worker has successfully claimed $425,000 in compensation for malignant mesothelioma, which developed as a result of asbestos exposure during the 1970s.

Zorko Zabic, 74, was denied compensation by a Supreme Court ruling in January as he did not make the claim within the period outlined in the statute of limitation.

Zabic began to experience chest pains in January 2014, after a typically long latency period for that type of cancer, but it was ruled a year later that his claim was statute-barred as it should have been filed before 1987.

Asbestos victim wins right to claim compo

Justice Barr said at the time he was satisfied that Zabic’s condition was caused by unprotected exposure to asbestos dust and fibres during his employment as a result of negligence by Alcan Gove (purchased by Rio Tinto).

However, Justice Chief Riley has told the Court of Appeal that Zabic’s appeal has been granted.

Zabic’s lawyer Roger Singh of Shine Lawyers said the decision would pave the way for other asbestos victims in the Northern Territory previously denied the ability to make similar claims, ABC reported.

“Today’s decision is a win for workers, a win for their families and a win for humanity,” he said last week.

A spokesman for Rio Tinto said although company did not own the refinery at the time of Zabic’s employment, they had sought to resolve the matter fairly as owner of the site.

“Given that the NT had abolished the right to bring common law claims from 1987, it was our understanding that the correct process under Northern Territory legislation was for Mr Zabic to lodge a statutory workers’ compensation claim,” he said.

ooo

Henry Sapiecha

QLD SCIENTISTS DISCOVER CURE FOR TUMOURS WITH THE BLUSHWOOD BERRY IN THE FAR NORTH OF AUSTRALIA

Tuesday, October 7th, 2014
A dog called Oscar pre-treatment with the berry compound (L) and 15 days after treatment (R).blushwood berries image www.newcures.info
Photo: A dog called Oscar pre-treatment with the berry compound (L) and 15 days after treatment (R).
(Supplied: QIMR Berghofer Medical Institute)
Usually when you treat a tumour it takes several weeks for it to resolve, but this is very, very rapid. Dr Glen Boyle
A BERRY GOOD TREATMENT FOR REMOVING CANCER TUMOURS

Scientists have been surprised by the rapid cancer-fighting properties of a berry found only in Far North Queensland.

An eight-year study led by Dr Glen Boyle, from the QIMR Berghofer medical research institute in Brisbane, found a compound in the berry could kill head and neck tumours as well as melanomas.

An experimental drug derived from the berry, EBC-46, has so far been used on 300 animals, including cats, dogs and horses.

Dr Boyle said in 75 per cent of cases, the tumour disappeared and had not come back.

blushwood tree with berries image www.newcures.info

“There’s a compound in the seed – it’s a very, very complicated process to purify this compound and why it’s there in the first place, we don’t know,” he said.

“The compound works by three ways essentially: it kills the tumour cells directly, it cuts off the blood supply and it also activates the body’s own immune system to clean up the mess that’s left behind.”

There were no side effects, but what amazed scientists most was how fast it worked: the drug took effect within five minutes and tumours disappeared within days.

“The surprising thing for us and the thing that we don’t see very often is the speed with which this occurs,” Dr Boyle said.

“Usually when you treat a tumour it takes several weeks for it to resolve, but this is very, very rapid.

Dr Glen Boyle with berries from the blushwood tree found in far north Queensland. image www.newcures.info

“There’s a purpling of the area, of the tumour itself, and you see that within five minutes and you come back the next day and the tumour’s black and you come back a few days later and the tumour’s fallen off.”

The berry grows on the blushwood tree, which only grows in pockets of Far North Queensland.

“The tree is very, very picky on where it will grow,” Dr Boyle said.

“It’s only on the Atherton Tablelands at the moment and they’re trying to expand that to different places of course because it’d be nice to be able to grow it on a farm somewhere.

Dr Boyle said the findings of the pre-clinical trials suggested the drug could be effective in human patients.

But Dr Boyle warned the drug could only be used for tumours that can be accessed by direct injection and was not effective against metastatic cancers.

He said it would be an additional treatment option, rather than a replacement for chemotherapy or surgery.

“Elderly patients for example who just can’t go through another round of chemo or can’t go through another general anaesthetic for example, this could be used to treat those sorts of tumours and hopefully improve quality of life for people,” he said.

Biotechnology company QBiotics has obtained ethical approval to begin human trials.

Beautiful_Russian_2_300_250

Henry Sapiecha

HORROR STORIES OF TREATMENTS & SCARY HEALTH ISSUES ON THESE 20 VIDEOS

Saturday, August 16th, 2014

1…BLACK SALVE OINTMENT TREATMENT.

OOO

2…Maggot found in Taiwanese woman’s ear after

she complained about earache


OOO

3…World’s Weirdest – Larva Removed from a

Girl’s Scalp

OOO

4…Blood Clot – Bizarre ER

OOO

5…Massive Head Splinter – Bizarre ER

OOO

6…Balloons in the Head | Bizarre ER

OOO

7…Growing Up Without A Face

OOO

8…Abigail & Brittany Hensel –

The Twins Who Share a Body

OOO

9…The Girl Who Never Ate –

Extraordinary People – Documentary

OOO

10…Nick Vujicic – No arms no legs no worries –

look at yourself after watching this!

OOO

11…The Eight-Limbed Boy – Documentary

OOO

12…The Boy Who Sees Without Eyes

OOO

13…Tourette’s Syndrome – Life With Tourette’s

OOO

14…10 Year Olds – Terri Calvesbert: Extraordinary

People – Documentary – My Shocking Story

OOO

15…My Face is Eating Me Alive – Documentary

OOO

16…The 46 Year Pregnancy – Documentary

OOO

17…Octopus Man – Documentary

OOO

18…I Woke Up in a Morgue – Documentary

OOO

19…The Boy With The Incredible Brain – Documentary

OOO

20…Shwachman – Diamond Syndrome (SDS) –

Documentary

Hope these above videos have been of value to you, if so give us a like and tell your friends about this site

Henry Sapiecha

IRREFUTABLE PROOF SAYS HEALTH INSTITUTE @ BALTIMORE USA THAT LEMONS & LIMES CURE CANCERS

Friday, August 3rd, 2012

The surprising benefits of lemon!

================================
Institute of Health Sciences, 819 N. L.L.C. Charles Street Baltimore , MD 1201.

This is the latest in medicine, effective for cancer! 
Read carefully & you be the judge. 
Lemon (Citrus) is a miraculous product to kill cancer cells.
Natures Brands Natural Health & Beauty Products

It is 10,000 times stronger than chemotherapy. 
Why do we not know about that? Because there are laboratories interested in making a synthetic version that will bring them huge profits. You can now help a friend in need by letting him/her know that lemon juice is beneficial in preventing the disease. Its taste is pleasant and it does not produce the horrific effects of chemotherapy.

How many people will die while this closely guarded secret is kept, so as not to jeopardize the beneficial multimillionaires large corporations? As you know, the lemon tree is known for its varieties of lemons and limes. You can eat the fruit in different ways: you can eat the pulp, juice press, prepare drinks, sorbets, pastries, etc… It is credited with many virtues, but the most interesting is the effect it produces on cysts and tumors. This plant is a proven remedy against cancers of all types.
Natures Brands Natural Health & Beauty Products

Some say it is very useful in all variants of cancer. It is considered also as an anti microbial spectrum against bacterial infections and fungi, effective against internal parasites and worms, it regulates blood pressure which is too high and an antidepressant, combats stress and nervous disorders.
The source of this information is fascinating: it comes from one of the largest drug manufacturers in the world, says that after more than 20 laboratory tests since 1970, the extracts revealed that:

 It destroys the malignant cells in 12 cancers, including colon, breast, prostate, lung and pancreas … The compounds of this tree showed 10,000 times better than the product Adriamycin, a drug normally used chemotherapeutic in the world, slowing the growth of cancer cells. And what is even more astonishing: this type of therapy with lemon extract only destroys malignant cancer cells and it does not affect healthy cells. 

The above lemon tree is one of several the publisher has on his property

Institute of Health Sciences, 819 N. L.L.C. Cause Street , Baltimore , MD120

 FAVOURITE DRINK OF THIS PUBLISHER IS NEAT SPIRITS & FRESH LIME OR LEMON JUICE

There’s hope for me yet it seems

Received & published by Henry Sapiecha
Natures Brands Natural Health & Beauty Products